• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Healthcare Data Blocking Wars: RTMS Defends Against PointClickCare’s Appeal

by Fred Pennic 11/04/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know: 

– Real Time Medical Systems (RTMS) is defending a preliminary injunction that prevents PointClickCare (PCC) from blocking RTMS’s access to patient electronic health records (EHRs). 

– PCC, which owns the EHR platform, attempted to block RTMS’s access to the data by implementing “indecipherable CAPTCHAs,” effectively preventing RTMS from providing its services.

Legal Dispute Overview

RTMS and PCC are competitors in the value-based care/patient analytics market. RTMS uses automated data collection to access patient EHRs stored on PCC’s platform to provide life-saving interventional analytics to Skilled Nursing Facilities (SNFs).  RTMS filed a lawsuit alleging unfair competition and tortious interference with contractual relations. The District Court granted a preliminary injunction in favor of RTMS, preventing PCC from blocking their access.

PCC’s Appeal

PCC is appealing the injunction, arguing that their actions are justified based on security concerns and the 21st Century Cures Act. RTMS argues that PCC’s actions were anti-competitive and motivated by a desire to eliminate a competitor. They claim PCC’s security and feasibility concerns are unfounded and that PCC does not have the right to block access to patient data that it does not own.

Information Blocking

RTMS contends that PCC’s actions constitute information blocking under the Cures Act, as they hindered the access, exchange, and use of electronic health information. RTMS argues that the Cures Act does not preempt their state law claims, as there is no private right of action under the Act and their claims involve conduct beyond the scope of the Act.

Impact for RTMS

RTMS asserts that they would suffer irreparable harm if the injunction is overturned, as they would be unable to access essential data and provide their services. RTMS argues that the balance of hardships favors them, as the injunction allows for fair competition and does not meaningfully burden PCC. The outcome of this appeal could set important precedents for future cases involving data blocking and interoperability in healthcare.

For more information about PointClickCare’s appeal to RTMS, click here

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Kinetik CEO Sufian Chowdhury on Fighting NEMT Fraud & Waste

Most-Read

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

WeightWatchers Files for Bankruptcy to Eliminate $1.15B in Debt

WeightWatchers Files for Bankruptcy to Eliminate $1.15B in Debt

KLAS: Epic Dominates 2024 EHR Market Share Amid Focus on Vendor Partnership; Oracle Health Sees Losses Despite Tech Advances

KLAS: Epic Dominates 2024 EHR Market Share Amid Focus on Vendor Partnership; Oracle Health Sees Losses Despite Tech Advances

'Cranky Index' Reveals EHR Alert Frustration Peaks Midweek, Highest Among Admin Staff

‘Cranky Index’ Reveals EHR Alert Frustration Peaks Midweek, Highest Among Admin Staff

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |